Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about INCY

Recent news which mentions INCY

< Previous 1 2 3 4 5 6 7 8 9 Next >
What's Up With Incyte Stock Lately?
Tickers INCY
Tags Market News Movers Benzinga
From Benzinga
S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets
Tickers ALB ALGN ALK APA
Tags BIIB UAL SLB
From Benzinga
Goldman Sachs Downgrades Incyte Amid Concerns Over Jakafi Studies, Competitiveness
Tickers INCY
Tags Analyst Ratings Analyst Color Downgrades
From Benzinga
The Latest Analyst Ratings for Incyte
Tickers INCY
Tags Market News Benzinga INCY
From Benzinga
3 Biotech Stocks That Are Poised to Have Breakthroughs in 2024
Tickers CRSP INCY SWAV
Tags Market News NASDAQ:SWAV,NASDAQ:CRSP,NASDAQ:INCY INCY
From InvestorPlace
7 Underappreciated Biotech Stocks to Pick Up on the Cheap
Tickers BNTX CORT GMAB HALO
Tags KNSA NASDAQ:REGN,NASDAQ:BNTX,NYSE:PFE,NASDAQ:HALO,NASDAQ:CORT,NASDAQ:INCY,NASDAQ:GMAB,NASDAQ:KNSA INCY
From InvestorPlace
Goldman Sachs Maintains Buy Rating for Incyte: Here's What You Need To Know
Tickers INCY
Tags BZI/AAR/UPDATE Market News INCY
From Benzinga
Earnings Outlook For Incyte
Tickers INCY
Tags BZI/EP Market News INCY
From Benzinga
Quant Ratings Updated on 73 Stocks
Tickers ABT AWK CL CNI
Tags Market News STLA Market Analysis
From InvestorPlace
Expert Ratings for Incyte
Tickers INCY
Tags Analyst Ratings BZI/AAR Market News
From Benzinga
3 Biotech Stocks That Should Be on Every Investor’s Radar This Fall
Tickers EXEL INCY JAZZ
Tags Market News INCY NASDAQ:JAZZ,NASDAQ:INCY,NASDAQ:EXEL
From InvestorPlace
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
Tickers BMY GSK INCY
Tags Market News Analyst Color Markets
From Benzinga
Analyst Ratings for Incyte
Tickers INCY
Tags BZI/AAR Analyst Ratings Market News
From Benzinga
Incyte's Jakafi Patent Expiry In 2028 Poses Challenge, Analyst Says New Treatments To Battle For Market Share
Tickers INCY
Tags Analyst Color Market News Analyst Ratings
From Benzinga
Incyte's Earnings Outlook
Tickers INCY
Tags BZI/EP Benzinga INCY
From Benzinga
Cathie Wood's Ark Invest Buys Spotify, Iridium Shares — Trims Tesla, Coinbase Holdings
Tickers ACCD AIR ARKQ ARKW
Tags Markets Cathie Wood Market News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2023
Tickers ABBV AGLE AI AVNS
Tags KVUE WMT CWH
From Benzinga
Syndax-Incyte Partnered Chronic Graft-Versus-Host Disease Achieves Primary Endpoint In Pivotal Trial, FDA Submission Planned By 2023 End
Tickers INCY SNDX
Tags Market News General Small Cap
From Benzinga
'I Don't Want You To Touch That': Cramer Rejects Stock Down 32% Over Past Month, Prefers Tesla
Tickers ARE ASTS CNC FRT
Tags Long Ideas CNC Benzinga
From Benzinga
Incyte Skin Disease Drug Meets Primary Goal In Late-Stage Study In Children
Tickers INCY
Tags Briefs News Health Care
From Benzinga
Syndax Pharmaceuticals Set for Potential Breakthrough with Revumenib: Analyst Calls It 'Potentially Best-In-Class' In Competitive Landscape
Tickers INCY SNDX
Tags Small Cap General Biotech
From Benzinga
2 Low-Priced Stocks That Could Make You Richer
Tickers ACRS AGEN AXSM BMY
Tags Recent Press Releases AXSM INCY
From Motley Fool
The bull market has left these 20 companies behind, but they are primed for growth
Tickers AAPL AMZN BLK CI
Tags GOOGL MTCH PODD
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
Tickers ABSI BLDR BLKB CERE
Tags ABSI HT RBA
From Benzinga
Why Incyte Shares Are Falling Today
Tickers INCY
Tags Market News General why it's moving
From Benzinga
Earnings Outlook For Incyte
Tickers INCY
Tags BZI/EP Market News INCY
From Benzinga
What To Expect When Incyte Reports Q1 Earnings In Almost Two Weeks
Tickers CTIC INCY
Tags CTIC Small Cap General
From Benzinga
7 Biotech Stocks That Could Cure Your Portfolio Woes
Tickers ARGX BGNE BMRN INCY
Tags LEGN BGNE TECH
From InvestorPlace
Ominous Death Cross Forms On Incyte's Chart
Tickers INCY
Tags Market News BZI/CROSS Markets
From Benzinga
Incyte Faces Increased Competition From Emerging JAK Inhibitors, RBC Capital Lowers Price Target
Tickers INCY
Tags Market News Downgrades Analyst Color
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.